PUBLISHER: The Business Research Company | PRODUCT CODE: 1939277
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939277
Artificial ventilation and anesthesia masks are medical devices designed to cover a patient's nose and mouth, providing a sealed interface for the controlled delivery of oxygen, ambient air, or anesthetic gases during medical procedures. These masks are essential for supporting or fully managing a patient's breathing, especially during surgeries, intensive care, or emergency interventions, ensuring respiratory stability and patient safety.
The key types of artificial ventilation and anesthesia masks are invasive ventilation masks and non-invasive ventilation masks. Invasive ventilation involves delivering air to the lungs through a tube inserted into the patient's trachea, commonly via an endotracheal or tracheostomy tube. This category includes disposable and reusable masks and serves various end users, including operating rooms, intensive care units, emergency rooms, homecare, and ambulatory surgical centers.
Tariffs are impacting the artificial ventilation and anesthesia masks market by increasing the cost of imported components such as specialized polymers, valves, and precision fittings, leading to higher production costs. Segments such as disposable masks and invasive ventilation devices are particularly affected, with regions like North America and Europe facing notable cost pressures due to import duties. While tariffs create challenges in supply chain management and pricing, they also encourage local manufacturing and innovation, enabling domestic producers to enhance production efficiency and reduce dependency on imports.
The artificial ventilation and anesthesia masks market research report is one of a series of new reports from The Business Research Company that provides artificial ventilation and anesthesia masks market statistics, including artificial ventilation and anesthesia masks industry global market size, regional shares, competitors with a artificial ventilation and anesthesia masks market share, detailed artificial ventilation and anesthesia masks market segments, market trends and opportunities, and any further data you may need to thrive in the artificial ventilation and anesthesia masks industry. This artificial ventilation and anesthesia masks market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial ventilation and anesthesia masks market size has grown strongly in recent years. It will grow from $2.32 billion in 2025 to $2.48 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to limited availability of advanced ventilation devices, rising surgical procedures, increasing icu infrastructure, growing prevalence of respiratory disorders, reliance on reusable mask solutions.
The artificial ventilation and anesthesia masks market size is expected to see strong growth in the next few years. It will grow to $3.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological advancements in non-invasive and invasive ventilation, increasing homecare and ambulatory respiratory services, rising geriatric population, growing demand for disposable masks, expansion of operating rooms and icu facilities globally. Major trends in the forecast period include rising demand for advanced ventilation support devices, increasing use of disposable masks to reduce cross-contamination, growing adoption of homecare and ambulatory ventilation solutions, enhanced focus on patient safety and respiratory monitoring, expansion of intensive care and emergency facilities.
The rising incidence of respiratory diseases is expected to propel the growth of the artificial ventilation and anesthesia mask market going forward. Respiratory diseases refer to conditions affecting the lungs, airways, and respiratory muscles, such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). The prevalence of these diseases is increasing due to prolonged exposure to air pollution, including fine particulate matter and toxic gases, which damage lung tissue and trigger inflammation. Artificial ventilation and anesthesia masks aid in managing respiratory diseases by delivering precise oxygen or anesthetic gases during surgeries, intensive care, or emergencies, maintaining stable respiratory function. For instance, in June 2025, according to the Office for Health Improvement and Disparities in the UK, emergency admissions for respiratory diseases in England increased by 7% between 2023 and 2024, including a 9% rise for COPD, 17% for adult asthma, and 16% for pneumonia. Therefore, the rising incidence of respiratory diseases is driving the growth of the artificial ventilation and anesthesia mask market.
Major companies operating in the global artificial ventilation and anesthesia masks market are concentrating on the development of advanced solutions, such as aerosol-reducing non-invasive ventilation (NIV) masks, to improve patient safety, limit healthcare worker exposure, and reduce the risk of airborne infections. Aerosol-reducing NIV masks use a negative-pressure gradient mechanism to capture exhaled aerosols, unlike conventional masks that permit unfiltered exhaled air to spread into the surrounding environment, thereby providing enhanced protection in high-risk clinical settings. For example, in February 2025, GaleMed Corporation, a Taiwan-based medical device manufacturer, announced a commercialization partnership with Inspir Labs, an Israel-based medical innovation company, to introduce a new NIV mask to the market, promoted as the world's first aerosol-safe ventilation mask. The mask incorporates a dual-layer silicone cushion, where the inner layer supports patient ventilation and the outer layer is connected to suction equipment to actively collect aerosols, thereby reducing airborne contamination. Its ergonomic shape, lightweight construction, and quick-release headgear clips improve both comfort and ease of use in clinical settings.
In February 2025, GaleMed Corporation, a Taiwan-based manufacturer of respiratory and anesthesia consumables, partnered with Israel-based Inspir Labs to launch the Lumena mask. The collaboration aims to enhance non-invasive ventilation safety by reducing aerosol dispersion and protecting patients and healthcare workers worldwide.
Major companies operating in the artificial ventilation and anesthesia masks market are Cardinal Health Inc., Air Liquide Medical Systems S.A., Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies Inc., ResMed Inc., Teleflex Incorporated, Getinge AB, Fisher & Paykel Healthcare Corporation Limited, Dragerwerk AG & Co. KGaA, Ambu A/S, Hamilton Medical AG, GaleMed Corporation, Armstrong Medical Ltd., Cathwide Medical Inc., Romsons Scientific and Surgical Industries Pvt. Ltd., Trudell Medical International, Besmed Health Business Corporation, Flexicare Medical Limited, Intersurgical Ltd., O-Two Medical Technologies Inc., Hans Rudolph Inc.
North America was the largest region in the artificial ventilation and anesthesia masks market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial ventilation and anesthesia masks market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial ventilation and anesthesia masks market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial ventilation and anesthesia masks market consists of sales of disposable anesthesia masks, reusable anesthesia masks, continuous positive airway pressure (CPAP) masks, bilevel positive airway pressure (BiPAP) masks, and high-flow oxygen masks. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Ventilation And Anesthesia Masks Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial ventilation and anesthesia masks market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial ventilation and anesthesia masks ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial ventilation and anesthesia masks market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.